These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8164019)

  • 1. Dyskinesias possibly induced by norpseudoephedrine.
    Thiel A; Dressler D
    J Neurol; 1994 Jan; 241(3):167-9. PubMed ID: 8164019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance does not develop to the suppressant effects of (-)-norpseudoephedrine on ingestive behavior in the rat.
    Nencini P; Fraioli S; Perrella D
    Pharmacol Biochem Behav; 1996 Feb; 53(2):297-301. PubMed ID: 8808135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Norpseudoephedrine, but not (+/-)-amphetamine, prevents the increase in fluid intake associated with ethanol presentation in rats.
    Nencini P; Valeri P
    Pharmacol Res; 1991 Jul; 24(1):83-91. PubMed ID: 1946145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perimesencephalic hemorrhage and intake of norpseudoephedrine].
    Vercueil L; Bazin A; Sellal F
    Rev Med Interne; 1998 Apr; 19(4):287-8. PubMed ID: 9775158
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products.
    McEwen J
    Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Norpseudoephedrine (norpseudoadrenaline) as a slimming agent is dangerous].
    Terland O
    Tidsskr Nor Laegeforen; 1983 Oct; 103(29):2002-3. PubMed ID: 6648942
    [No Abstract]   [Full Text] [Related]  

  • 7. Amphetamine-like reactions to phenylpropanolamine.
    Dietz AJ
    JAMA; 1981 Feb; 245(6):601-2. PubMed ID: 7452888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hazards of the appetite suppressant phenylpropanolamine.
    Bennett WM
    Lancet; 1979 Jul; 2(8132):42-3. PubMed ID: 87921
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurological and cardiac events on phenylpropanolamine.
    Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylpropanolamine and the risk of hemorrhagic stroke.
    Kernan WN; Viscoli CM; Brass LM; Broderick JP; Brott T; Feldmann E; Morgenstern LB; Wilterdink JL; Horwitz RI
    N Engl J Med; 2000 Dec; 343(25):1826-32. PubMed ID: 11117973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylpropanolamine and hemorrhagic stroke.
    Wolowich WR; Casavant MJ; Ekins BR
    N Engl J Med; 2001 Apr; 344(14):1094-5. PubMed ID: 11291666
    [No Abstract]   [Full Text] [Related]  

  • 12. Hidden amphetamines: from smoking cessation to diabetes.
    Prescrire Int; 2004 Feb; 13(69):18-20. PubMed ID: 15055218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis after ingestion of an appetite suppressant.
    Rumpf KW; Kaiser HF; Horstkotte H; Bahlmann J
    JAMA; 1983 Oct; 250(16):2112. PubMed ID: 6620516
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebral hemorrhage associated with the use of phenylpropanolamine. Clinical cases].
    Tapia J
    Rev Med Chil; 1996 Dec; 124(12):1499-503. PubMed ID: 9334487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral infarction with a single oral dose of phenylpropanolamine.
    Edwards M; Russo L; Harwood-Nuss A
    Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant.
    Smookler S; Bermudez AJ
    Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylpropanolamine anorexiants and affective disorders.
    Grigg JR; Goyer PF
    Mil Med; 1986 Jul; 151(7):387-8. PubMed ID: 3092141
    [No Abstract]   [Full Text] [Related]  

  • 19. (-)-Norpseudoephedrine, a metabolite of cathinone with amphetamine-like stimulus properties, enhances the analgesic and rate decreasing effects of morphine, but inhibits its discriminative properties.
    Nencini P; Fraioli S; Pascucci T; Nucerito CV
    Behav Brain Res; 1998 Apr; 92(1):11-20. PubMed ID: 9588681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tardive dystonia. A rare neuroleptic-induced disease picture].
    Assion HJ; Heinemann F
    Nervenarzt; 1994 Nov; 65(11):795-7. PubMed ID: 7816158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.